From veterinary clinics to large-scale producers, selling in animal health requires both technical credibility and a strategy that scales across complex, geographically spread accounts
Estimated Read Time: 7 minutes
Animal health is one of the most operationally demanding sales environments in the industry. Companies like Merck Animal Health and Boehringer Ingelheim field representatives who must be scientifically credible with veterinarians, commercially persuasive with livestock producers, and strategically sophisticated when navigating large buying groups and distribution agreements. The territory often spans hundreds of square miles. The buying cycles vary from immediate (a veterinarian needs product this week) to multi-year (a large swine producer evaluating a new vaccine protocol for an entire operation).
The reps who thrive in this environment are not just the ones with the most product knowledge—they are the ones with the most discipline around territory management, relationship maintenance, and the strategic use of every interaction to advance their position in the account.
A well-managed animal health territory starts with honest segmentation. Not all accounts are created equal, and the instinct to treat every veterinary clinic and every producer farm as equally worthy of attention is the fastest path to mediocre results everywhere.
Companion animal accounts (small animal clinics, specialty hospitals, emergency practices) operate on a different logic than production animal accounts (cow-calf operations, feedlots, swine and poultry integrators). The buying decision at a small animal clinic often comes down to the veterinarian’s personal preference and the rep’s relationship with the practice. The buying decision at a large swine integrator involves a team of veterinarians, a purchasing manager, and sometimes corporate leadership. Equine accounts have their own dynamics entirely.
Effective territory management starts with an annual account audit: Which accounts have the highest revenue potential? Which are currently buying competitive products and why? Which are growing their practice or production volume? Which relationships are genuinely warm versus merely cordial? The answers determine where your time goes.
Veterinarians are trained scientists who are appropriately skeptical of sales claims that are not grounded in clinical evidence. The reps who build the deepest relationships with DVMs are the ones who invest in genuine scientific fluency—not just knowing the data sheets but understanding the mechanisms, the clinical scenarios where the product performs best, and the competitive landscape well enough to have honest conversations about trade-offs.
But clinical credibility alone does not close deals in a veterinary practice. Practice economics matter too. A companion animal clinic is a business, and the practice owner or manager is thinking about inventory turns, client compliance rates, profit margins on pharmaceutical sales, and the value of recommending products that clients will actually use and refill. The rep who understands both the clinical case and the business case for their product is the one who gets on the preferred product list and stays there.
Selling to large livestock producers—whether beef cow-calf operations, feedlot finishing programs, swine integrators, or commercial poultry operations—is closer to enterprise B2B sales than to traditional pharmaceutical detailing. The buyer is sophisticated, the stakes are high, and the decision is made analytically.
Production animal buyers think in the language of performance metrics: cost per head treated, mortality rates, ADG (average daily gain), feed conversion efficiency, return on vaccine investment. The rep who walks in with an ROI model showing how their respiratory vaccine program affects close-out performance is having a fundamentally different conversation than the rep who leads with product features. This requires doing the homework—understanding the operation’s production model, knowing their current protocol costs, and building a tailored business case rather than delivering a generic presentation.
The relationship dynamic in large animal accounts is also longer-term. A large beef operation might take three years to switch vaccine protocols, but once they switch, they are extremely sticky. The investment in building the relationship and the business case pays off over a multi-year horizon.
The consolidation of veterinary practices into corporate groups (like VCA, National Veterinary Associates, and similar regional chains) and the growth of producer buying cooperatives have created a new dynamic in animal health sales. These accounts require a key account management approach—not just rep-level relationship management, but coordinated selling across multiple levels of the organization.
A key account strategy for a large corporate veterinary group means having relationships at the corporate purchasing level, at the regional medical director level, and at the individual clinic level simultaneously. It means understanding the formulary process and how products get approved for system-wide use. It means having a value proposition that speaks to corporate priorities (standardization, pricing, supply reliability) as well as clinical preferences at the practice level. This is sophisticated selling that most reps are not trained for explicitly—but that the top performers figure out early.
Animal health territories are large. Most reps are covering hundreds of accounts across a geographic area that might require hours of driving between stops. The operational challenge is maintaining genuine relationship depth across a portfolio that size without letting important accounts go dormant.
The reps who do this best have a systematic approach to account prioritization and call planning. They know which accounts get monthly visits, which get quarterly, and which get annual check-ins. They have a process for following up on every clinical commitment they make in a call. And critically, they capture what happened in each call immediately—a quick voice note on the drive between farms is infinitely more reliable than trying to reconstruct conversation details at the end of a ten-stop day. Voice-based CRM capture is particularly well-suited to field-based reps in animal health, where the pace of the day makes traditional note-taking impractical.
The detail that differentiates the best animal health reps from the average ones is often not the science or the strategy—it’s the follow-through. Remembering that a producer mentioned a respiratory challenge in his yearling heifers six weeks ago and following up with relevant data. Recalling that a veterinarian was skeptical of a particular efficacy claim and coming back with the specific study that addresses it. Noticing that a clinic manager mentioned they were struggling with a particular protocol and checking in to see how it went.
These details build genuine relationships. They communicate that you were paying attention, that you took the account seriously, and that you came back. That kind of follow-through is not possible if notes are not captured consistently and systematically. It is the discipline behind the relationship. For more on how territory-based sales professionals are managing this, explore Hey DAN’s capabilities for field sales teams.
